poisar

Stocks · News reference

8-K filing — Kairos Pharma, LTD. (KAPA)

SEC EDGARAug 21, 2026, 8:30 PMSEC EDGAR

Filed: 2026-08-21 AccNo: 0001493152-26-039695 Size: 264 KB Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
edgar
Observed
Aug 21, 2026, 8:30 PM
Checked
Aug 21, 2026, 8:30 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading